Creative Medical Technol...【CELZ】銘柄情報

Creative Medical Technology Holdings Inc (CELZ) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

2.2572

( 4.02% )

買値

2.25

売値

2.43

出来高

81,901

2.11 日の範囲 2.39

1.504 52 週間の範囲 6.25

時価総額

8.344M

前日終値

2.17

始値

2.20

時刻

100

2.2572

(formt)

最終取引時間

07:18:46

財務取引量

US$ 184,392

VWAP

2.2514

平均取引量 (3 か月)

US$ 58,122

発行済株式数

3,696,668

配当利回り

PER

-1.06

1 株当たり利益 (EPS)

-2.05

歳入

純利益

-5.76M

Creative Medical Technology Holdings, Inc., a commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction, and FemC... Creative Medical Technology Holdings, Inc., a commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction, and FemCelz for the treatment of loss of genital sensitivity and dryness. It develops AlloStem (CELZ-201-DDT), a allogenic human perinatal tissue derived cell program, ImmCelz (CELZ-100), a personalized supercharged immune therapy platform; CELZ-201 CREATE-1, which is phase 2, for the treatment of type 1 diabetes; AlloStemSpine (CELZ 201 ADAPT), which is phase 2, for the treatment of chronic lower back pain; Alova, a platform to treat infertility as a result of premature ovarian failure; StemSpine, a regenerative stem cell procedure to treat degenerative disc disease; OvaStem, a stem cell therapy for premature ovarian failure; CaverStem for erectile dysfunction treatment; and FemCelz for female sexual function treatment. In addition, the company develops products and services for various indications, including preventing the rejection of transplanted organs, kidney failure, liver failure, heart attack, and Parkinson’s disease. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

www.creativemedicaltechnology.com

本社

Phoenix, United States

設立

Creative Medical Technology Holdings Inc is listed in the Healthcare sector of the ナスダック市場 with ticker CELZ. The last closing price for Creative Medical Technol... was US$2.17. Over the last year, Creative Medical Technol... shares have traded in a share price range of US$ 1.504 to US$ 6.25.

Creative Medical Technol... currently has 3,696,668 shares in issue. The market capitalisation of Creative Medical Technol... is US$8.34 million. Creative Medical Technol... has a price to earnings ratio (PE ratio) of -1.06.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Creative Medical Technology Holdings, Inc. Reports Breakthrough 93% Response Rate in Ultrasome™ Knee Osteoarthritis Program, Expanding CELZ-201 Platform into Scalable Cell-Free Regenerative Therapies

Ultrasome™ Demonstrates Strong Clinical Signal While Leveraging GMP-Produced CELZ-201 (Olastrocel) to Target...

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Creative Medical Technology Holdings Achieves Second WHO INN Milestone, Strengthening Global Regulatory Positioning Across Expanding Cell Therapy Pipeline

PHOENIX, Feb. 10, 2026 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ...

Creative Medical Technology Holdings Reaches Major Clinical Inflection Point with Positive Interim Data from ADAPT Trial and CELZ-201 (Olastrocel) in the Treatment of Chronic Lower Back Pain

PHOENIX, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ...

Creative Medical Technology Holdings Receives Regulatory Approval for BioDefense Burn Pit Initiative

PHOENIX, Jan. 06, 2026 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ...

Form 8-K - Current report

Creative Medical Technology Holdings, Inc. Completes Enrollment in FDA-Cleared ADAPT Trial for CELZ-201-Olastrocel, Marking Major Clinical Inflection Point

PHOENIX, Dec. 17, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.1572	7.48571428571	2.1	2.39	2.07	22276	2.15321373	CS
4	-0.0028	-0.12389380531	2.26	2.4	2.0029	49685	2.22733694	CS
12	0.3472	18.1780104712	1.91	2.48	1.78	60474	2.21067525	CS
26	0.1072	4.98604651163	2.15	2.4999	1.504	66989	2.09740823	CS
52	0.1072	4.98604651163	2.15	6.25	1.504	94541	2.87109834	CS
156	-2.1528	-48.8163265306	4.41	10.2812	1.504	75327	3.92811192	CS
260	-0.9428	-29.4625	3.2	10.2812	0.33	750267	2.18033437	CS

CELZ - Frequently Asked Questions (FAQ)

What is the current Creative Medical Technology Holdings Inc share price?

The current share price of Creative Medical Technology Holdings Inc is US$ 2.2572

How many Creative Medical Technology Holdings Inc shares are in issue?

Creative Medical Technology Holdings Inc has 3,696,668 shares in issue

What is the market cap of Creative Medical Technology Holdings Inc?

The market capitalisation of Creative Medical Technology Holdings Inc is USD 8.34M

What is the 1 year trading range for Creative Medical Technology Holdings Inc share price?

Creative Medical Technology Holdings Inc has traded in the range of US$ 1.504 to US$ 6.25 during the past year

What is the PE ratio of Creative Medical Technology Holdings Inc?

The price to earnings ratio of Creative Medical Technology Holdings Inc is -1.06

What is the cash to sales ratio of Creative Medical Technology Holdings Inc?

The cash to sales ratio of Creative Medical Technology Holdings Inc is 2.67k

What is the registered address of Creative Medical Technology Holdings Inc?

The registered address for Creative Medical Technology Holdings Inc is 211 East Osborn Road, Phoenix, Arizona, 85012

What is the Creative Medical Technology Holdings Inc website address?

The website address for Creative Medical Technology Holdings Inc is www.creativemedicaltechnology.com

Which industry sector does Creative Medical Technology Holdings Inc operate in?

Creative Medical Technology Holdings Inc operates in the Biotechnology & Life Sciences sector

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Creative Medical Technology Holdings Inc (CELZ)

Creative Medical Technology Holdings Inc (CELZ) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

主要統計と詳細

Creative Medical Technology Holdings Inc について

CELZ 最新ニュース

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Creative Medical Technology Holdings, Inc. Reports Breakthrough 93% Response Rate in Ultrasome™ Knee Osteoarthritis Program, Expanding CELZ-201 Platform into Scalable Cell-Free Regenerative Therapies

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Creative Medical Technology Holdings Achieves Second WHO INN Milestone, Strengthening Global Regulatory Positioning Across Expanding Cell Therapy Pipeline

Creative Medical Technology Holdings Reaches Major Clinical Inflection Point with Positive Interim Data from ADAPT Trial and CELZ-201 (Olastrocel) in the Treatment of Chronic Lower Back Pain

Creative Medical Technology Holdings Receives Regulatory Approval for BioDefense Burn Pit Initiative

Form 8-K - Current report

Form 8-K - Current report

Creative Medical Technology Holdings, Inc. Completes Enrollment in FDA-Cleared ADAPT Trial for CELZ-201-Olastrocel, Marking Major Clinical Inflection Point

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Creative Medical Technology Holdings, Inc. Reports Breakthrough 93% Response Rate in Ultrasome™ Knee Osteoarthritis Program, Expanding CELZ-201 Platform into Scalable Cell-Free Regenerative Therapies

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Creative Medical Technology Holdings Achieves Second WHO INN Milestone, Strengthening Global Regulatory Positioning Across Expanding Cell Therapy Pipeline

Creative Medical Technology Holdings Reaches Major Clinical Inflection Point with Positive Interim Data from ADAPT Trial and CELZ-201 (Olastrocel) in the Treatment of Chronic Lower Back Pain

Creative Medical Technology Holdings Receives Regulatory Approval for BioDefense Burn Pit Initiative

Form 8-K - Current report

Form 8-K - Current report

Creative Medical Technology Holdings, Inc. Completes Enrollment in FDA-Cleared ADAPT Trial for CELZ-201-Olastrocel, Marking Major Clinical Inflection Point

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form EFFECT - Notice of Effectiveness

CELZ - Frequently Asked Questions (FAQ)

CELZ 取引

CELZ Discussion

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

無料で登録してください:

広告を削除する